GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Regulatory] 503A vs 503B in one paragraph, because everyone conflates them — 18 comments in the full submission. View in context.
565
c/compounding·submitted 3 days ago by u/rania_diallo

[Regulatory] 503A vs 503B in one paragraph, because everyone conflates them

Regulatorybranch of 6 comments

Right, the 503A question again, but with numbers this time. I have 11 data points over 18 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am describing…

Read the full submission and all 18 comments →

This branch

6 comments, started 2 days ago
u/formulary_fighterappeals57 points·2 days ago

API source questions are on-topic and compounders dodging them is newsworthy

replysharereportpermalink
[removed]42 points·1 days ago

[removed by moderator]

replysharereportpermalink
u/ferran_mensah31 points·2 days ago

Disagree. What you are describing is consistent with 503A, not with what you concluded.

replysharereportpermalink
u/ilias_cabrera26 points·2 days ago

telehealth costs compounding plus compounding markup, total varies

replysharereportpermalink
u/tb500_tangent16 points·2 days ago·edited

Strongly agree. API source transparency matters.

replysharereportpermalink
u/amara_kuipers-26 points·2 days ago

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →